(IHG) InterContinental Hotels - Overview
Exchange: NYSE •
Country: United Kingdom •
Currency: USD •
Type: Common Stock •
ISIN: US45857P8068
Stock: Hotels, Resorts, Loyalty Program
Total Rating 55
Risk 68
Buy Signal -0.36
| Risk 5d forecast | |
|---|---|
| Volatility | 28.1% |
| Relative Tail Risk | -5.69% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.61 |
| Alpha | -2.92 |
| Character TTM | |
|---|---|
| Beta | 1.047 |
| Beta Downside | 1.356 |
| Drawdowns 3y | |
|---|---|
| Max DD | 28.13% |
| CAGR/Max DD | 1.01 |
EPS (Earnings per Share)
Revenue
Description: IHG InterContinental Hotels March 05, 2026
InterContinental Hotels Group PLC (IHG) operates globally, owning, managing, franchising, and leasing hotel properties. The company utilizes a brand portfolio exceeding 20 names, including Six Senses, InterContinental Hotels & Resorts, and Holiday Inn. This multi-brand strategy is common in the hospitality sector, allowing companies to target diverse customer segments.
IHG also manages a customer loyalty program, IHG Rewards. These programs are standard in the hotel industry, designed to encourage repeat business and brand loyalty among travelers.
For more detailed financial and operational insights, consider exploring ValueRays comprehensive analysis.
Founded in 1777, IHG is headquartered in Windsor, UK.
Headlines to watch out for
- Global travel demand recovery boosts hotel occupancy rates
- Brand expansion into luxury and lifestyle segments increases revenue
- Wage inflation and energy costs pressure operating margins
- Geopolitical instability impacts international tourism
- Loyalty program growth enhances customer retention and direct bookings
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 1.39b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.29 > 0.02 and ΔFCF/TA 2.26 > 1.0 |
| NWC/Revenue: -0.50% < 20% (prev -1.01%; Δ 0.51% < -1%) |
| CFO/TA 0.30 > 3% & CFO 1.62b > Net Income 1.39b |
| Net Debt (3.49b) to EBITDA (2.39b): 1.46 < 3 |
| Current Ratio: 0.98 > 1.5 & < 3 |
| Outstanding Shares: last quarter (153.8m) vs 12m ago -7.35% < -2% |
| Gross Margin: 45.69% > 18% (prev 0.48%; Δ 4.52k% > 0.5%) |
| Asset Turnover: 199.5% > 50% (prev 125.5%; Δ 74.07% > 0%) |
| Interest Coverage Ratio: 9.87 > 6 (EBITDA TTM 2.39b / Interest Expense TTM 223.8m) |
Altman Z'' 2.32
| A: -0.01 (Total Current Assets 2.05b - Total Current Liabilities 2.10b) / Total Assets 5.34b |
| B: -0.06 (Retained Earnings -302.0m / Total Assets 5.34b) |
| C: 0.43 (EBIT TTM 2.21b / Avg Total Assets 5.08b) |
| D: -0.34 (Book Value of Equity -2.74b / Total Liabilities 8.08b) |
| Altman-Z'' Score: 2.32 = BBB |
Beneish M -2.57
| DSRI: 0.85 (Receivables 880.0m/615.0m, Revenue 10.13b/6.04b) |
| GMI: 1.05 (GM 45.69% / 48.17%) |
| AQI: 1.15 (AQ_t 0.54 / AQ_t-1 0.47) |
| SGI: 1.68 (Revenue 10.13b / 6.04b) |
| TATA: -0.04 (NI 1.39b - CFO 1.62b) / TA 5.34b) |
| Beneish M-Score: -2.57 (Cap -4..+1) = A |
What is the price of IHG shares?
As of March 17, 2026, the stock is trading at USD 130.91 with a total of 163,081 shares traded.
Over the past week, the price has changed by -1.27%, over one month by -11.68%, over three months by -6.77% and over the past year by +17.53%.
Over the past week, the price has changed by -1.27%, over one month by -11.68%, over three months by -6.77% and over the past year by +17.53%.
Is IHG a buy, sell or hold?
InterContinental Hotels has received a consensus analysts rating of 3.75.
Therefor, it is recommend to hold IHG.
- StrongBuy: 1
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the IHG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 137 | 4.7% |
| Analysts Target Price | 137 | 4.7% |
IHG Fundamental Data Overview March 14, 2026
P/E Trailing = 26.8891
P/E Forward = 22.2222
P/S = 3.7765
P/B = 25.8882
P/EG = 0.9925
Revenue TTM = 10.13b USD
EBIT TTM = 2.21b USD
EBITDA TTM = 2.39b USD
Long Term Debt = 3.72b USD (from longTermDebt, last quarter)
Short Term Debt = 506.0m USD (from shortTermDebt, last quarter)
Debt = 4.62b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.49b USD (from netDebt column, last quarter)
Enterprise Value = 23.09b USD (19.60b + Debt 4.62b - CCE 1.13b)
Interest Coverage Ratio = 9.87 (Ebit TTM 2.21b / Interest Expense TTM 223.8m)
EV/FCF = 14.78x (Enterprise Value 23.09b / FCF TTM 1.56b)
FCF Yield = 6.76% (FCF TTM 1.56b / Enterprise Value 23.09b)
FCF Margin = 15.41% (FCF TTM 1.56b / Revenue TTM 10.13b)
Net Margin = 13.72% (Net Income TTM 1.39b / Revenue TTM 10.13b)
Gross Margin = 45.69% ((Revenue TTM 10.13b - Cost of Revenue TTM 5.50b) / Revenue TTM)
Gross Margin QoQ = 36.67% (prev 25.49%)
Tobins Q-Ratio = 4.32 (Enterprise Value 23.09b / Total Assets 5.34b)
Interest Expense / Debt = 0.06% (Interest Expense 3.00m / Debt 4.62b)
Taxrate = 34.24% (151.0m / 441.0m)
NOPAT = 1.45b (EBIT 2.21b * (1 - 34.24%))
Current Ratio = 0.98 (Total Current Assets 2.05b / Total Current Liabilities 2.10b)
Debt / Equity = -1.69 (negative equity) (Debt 4.62b / totalStockholderEquity, last quarter -2.74b)
Debt / EBITDA = 1.46 (Net Debt 3.49b / EBITDA 2.39b)
Debt / FCF = 2.23 (Net Debt 3.49b / FCF TTM 1.56b)
Total Stockholder Equity = -2.48b (last 4 quarters mean from totalStockholderEquity)
RoA = 27.37% (Net Income 1.39b / Total Assets 5.34b)
RoE = -56.16% (negative equity) (Net Income TTM 1.39b / Total Stockholder Equity -2.48b)
RoCE = 177.0% (EBIT 2.21b / Capital Employed (Equity -2.48b + L.T.Debt 3.72b))
RoIC = 131.7% (NOPAT 1.45b / Invested Capital 1.10b)
WACC = 7.91% (E(19.60b)/V(24.22b) * Re(9.77%) + D(4.62b)/V(24.22b) * Rd(0.06%) * (1-Tc(0.34)))
Discount Rate = 9.77% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.74%
[DCF] Terminal Value 81.54% ; FCFF base≈1.46b ; Y1≈1.80b ; Y5≈3.06b
[DCF] Fair Price = 328.2 (EV 52.60b - Net Debt 3.49b = Equity 49.11b / Shares 149.6m; r=7.91% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 11.00 | EPS CAGR: 16.07% | SUE: 0.49 | # QB: 0
Revenue Correlation: 82.44 | Revenue CAGR: 58.78% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=5.91 | Chg7d=-0.009 | Chg30d=+0.120 | Revisions Net=-1 | Growth EPS=+0.0% | Growth Revenue=+6.4%
EPS next Year (2027-12-31): EPS=6.64 | Chg7d=+0.030 | Chg30d=-0.040 | Revisions Net=+0 | Growth EPS=+12.5% | Growth Revenue=+5.5%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 6.1% (Discount Rate 9.8% - Earnings Yield 3.7%)
[Growth] Growth Spread = -0.6% (Analyst 5.5% - Implied 6.1%)
P/E Forward = 22.2222
P/S = 3.7765
P/B = 25.8882
P/EG = 0.9925
Revenue TTM = 10.13b USD
EBIT TTM = 2.21b USD
EBITDA TTM = 2.39b USD
Long Term Debt = 3.72b USD (from longTermDebt, last quarter)
Short Term Debt = 506.0m USD (from shortTermDebt, last quarter)
Debt = 4.62b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.49b USD (from netDebt column, last quarter)
Enterprise Value = 23.09b USD (19.60b + Debt 4.62b - CCE 1.13b)
Interest Coverage Ratio = 9.87 (Ebit TTM 2.21b / Interest Expense TTM 223.8m)
EV/FCF = 14.78x (Enterprise Value 23.09b / FCF TTM 1.56b)
FCF Yield = 6.76% (FCF TTM 1.56b / Enterprise Value 23.09b)
FCF Margin = 15.41% (FCF TTM 1.56b / Revenue TTM 10.13b)
Net Margin = 13.72% (Net Income TTM 1.39b / Revenue TTM 10.13b)
Gross Margin = 45.69% ((Revenue TTM 10.13b - Cost of Revenue TTM 5.50b) / Revenue TTM)
Gross Margin QoQ = 36.67% (prev 25.49%)
Tobins Q-Ratio = 4.32 (Enterprise Value 23.09b / Total Assets 5.34b)
Interest Expense / Debt = 0.06% (Interest Expense 3.00m / Debt 4.62b)
Taxrate = 34.24% (151.0m / 441.0m)
NOPAT = 1.45b (EBIT 2.21b * (1 - 34.24%))
Current Ratio = 0.98 (Total Current Assets 2.05b / Total Current Liabilities 2.10b)
Debt / Equity = -1.69 (negative equity) (Debt 4.62b / totalStockholderEquity, last quarter -2.74b)
Debt / EBITDA = 1.46 (Net Debt 3.49b / EBITDA 2.39b)
Debt / FCF = 2.23 (Net Debt 3.49b / FCF TTM 1.56b)
Total Stockholder Equity = -2.48b (last 4 quarters mean from totalStockholderEquity)
RoA = 27.37% (Net Income 1.39b / Total Assets 5.34b)
RoE = -56.16% (negative equity) (Net Income TTM 1.39b / Total Stockholder Equity -2.48b)
RoCE = 177.0% (EBIT 2.21b / Capital Employed (Equity -2.48b + L.T.Debt 3.72b))
RoIC = 131.7% (NOPAT 1.45b / Invested Capital 1.10b)
WACC = 7.91% (E(19.60b)/V(24.22b) * Re(9.77%) + D(4.62b)/V(24.22b) * Rd(0.06%) * (1-Tc(0.34)))
Discount Rate = 9.77% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.74%
[DCF] Terminal Value 81.54% ; FCFF base≈1.46b ; Y1≈1.80b ; Y5≈3.06b
[DCF] Fair Price = 328.2 (EV 52.60b - Net Debt 3.49b = Equity 49.11b / Shares 149.6m; r=7.91% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 11.00 | EPS CAGR: 16.07% | SUE: 0.49 | # QB: 0
Revenue Correlation: 82.44 | Revenue CAGR: 58.78% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=5.91 | Chg7d=-0.009 | Chg30d=+0.120 | Revisions Net=-1 | Growth EPS=+0.0% | Growth Revenue=+6.4%
EPS next Year (2027-12-31): EPS=6.64 | Chg7d=+0.030 | Chg30d=-0.040 | Revisions Net=+0 | Growth EPS=+12.5% | Growth Revenue=+5.5%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 6.1% (Discount Rate 9.8% - Earnings Yield 3.7%)
[Growth] Growth Spread = -0.6% (Analyst 5.5% - Implied 6.1%)